AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,473,836 | +24.6% | 16,205,119 | 0.0% | 31.57% | +63.7% |
| Q2 2023 | $14,827,684 | +63.3% | 16,205,119 | 0.0% | 19.29% | +60.8% |
| Q1 2023 | $9,081,349 | +4.3% | 16,205,119 | +7.4% | 12.00% | +19.8% |
| Q4 2022 | $8,706,999 | +491.9% | 15,090,119 | +224.3% | 10.02% | +607.3% |
| Q3 2022 | $1,471,000 | -10.4% | 4,652,561 | 0.0% | 1.42% | -53.5% |
| Q2 2022 | $1,642,000 | -50.8% | 4,652,561 | 0.0% | 3.05% | -46.1% |
| Q1 2022 | $3,340,000 | -68.2% | 4,652,561 | 0.0% | 5.66% | -47.1% |
| Q4 2021 | $10,515,000 | -21.5% | 4,652,561 | 0.0% | 10.70% | +16.6% |
| Q3 2021 | $13,399,000 | -24.0% | 4,652,561 | 0.0% | 9.17% | -4.2% |
| Q2 2021 | $17,633,000 | +12.0% | 4,652,561 | 0.0% | 9.57% | +37.4% |
| Q1 2021 | $15,749,000 | +20.9% | 4,652,561 | 0.0% | 6.97% | +35.8% |
| Q4 2020 | $13,027,000 | – | 4,652,561 | – | 5.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
| Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
| WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
| Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |